Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-Human NMI Polyclonal Antibody (HD442014)

Anti-Human NMI Polyclonal Antibody
Anti-Human NMI Polyclonal Antibody
Price(USD):
Spec:
  • 20ug
  • 50ug
  • 100ug
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HD442014
Description
Anti-Human NMI Polyclonal Antibody (HD442014) is a rabbit polyclonal antibody detecting NMI in ELISA, IHC, WB. Suitable for Human.
Highlights
  • Affinity Purified — Minimal background and high purity for reliable results.
  • Multi-Application — Validated across multiple applications.
Species reactivityHuman
ApplicationsELISA, IHC, WB
Host speciesRabbit
IsotypeIgG
Clonality Polyclonal
Immunogen E. coli - derived recombinant Human NMI (Phe58-Glu307).
Target N-myc and STAT interactor, N-myc-interactor, NMI, Nmi
Endotoxin level Please contact with the lab for this information.
Purification Purified by antigen affinity column.
Accession Q13287
Form Liquid
Storage buffer 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information
Application Dilution
ELISA 1:5000-1:20000
IHC 1:50-1:500
WB 1:500-1:2000
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternate NamesQ13287
Background

N-myc-interactor (NMI) is a ~35 kDa protein. Acts as a signaling pathway regulator involved in innate immune system response. In response to interleukin 2/IL2 and interferon IFN-gamma/IFNG, interacts with signal transducer and activator of transcription/STAT which activate the transcription of downstream genes involved in a multitude of signals for development and homeostasis. Enhances the recruitment of CBP/p300 coactivators to STAT1 and STAT5, resulting in increased STAT1- and STAT5-dependent transcription. In response to interferon IFN-alpha, associates in a complex with signaling pathway regulator IFI35 to regulate immune response; the complex formation prevents proteasome-mediated degradation of IFI35. In complex with IFI35, inhibits virus-triggered type I IFN-beta production when ubiquitinated by ubiquitin-protein ligase TRIM21.

1. Das, A. et al. (2015) Virology 485, 383-92. PMID: 26342464
2. Xiahou, Z. et al. (2017) Nature communications 8, 950. PMID: 29038465
3. Jian, D. et al. (2018) Acta physiologica (Oxford, England) 223, e13037. PMID: 29350881
4. Zhu, M. et al. (1999) Cell 96, 121-30. PMID: 9989503
5. Feng, L. et al. (2018) PLoS pathogens 14, e1006867. PMID: 29377960
6. Zhou, X. et al. (2000) The Journal of biological chemistry 275, 21364-71. PMID: 10779520
7. Chen, J. et al. (2000) The Journal of biological chemistry 275, 36278-84. PMID: 10950963
Note For research use only
Images
  • Anti-Human NMI Polyclonal Antibody

    Western blot

    Western blot analysis was performed using anti-NMI polyclonal antibody at 1ug/mL on various samples.
    Lane 1: PC-3 cell lysate

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list